GW Pharmaceuticals

Latest stories

3d
Business Wire
Goldberg Law PC Announces Securities Class Action Lawsuit against GW Pharmaceuticals plc and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmThe class in this case has not yet been certified, and until certification occu
Goldberg Law PC Announces Securities Class Action Lawsuit against GW Pharmaceuticals plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Business Wire / Posted 3 days ago
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the complaint, the Company made false... Read more
8 related stories
4d
Business Wire
NTRR Joint Venture Submits Anti-Microbial Treatment Quotes to International Cruise LinesTAMPA, Fla.--(BUSINESS WIRE)--Aside from inclement weather, infectious disease
NTRR Joint Venture Submits Anti-Microbial Treatment Quotes to International Cruise Lines
Business Wire / Posted 4 days ago
TAMPA, Fla.--(BUSINESS WIRE)--Aside from inclement weather, infectious disease outbreaks are one of the few problems that can absolutely ruin a luxury cruise vacation. All-natural wellness company Neutra Corp. (OTCQB: NTRR) and its joint venture... Read more
8d
Business Wire
NTRR: Canada’s Cannabis Industry Could Hit $7 Billion in SalesTAMPA, Fla.--(BUSINESS WIRE)--As Neutra Corp. (OTCQB: NTRR) and other wellness
NTRR: Canada’s Cannabis Industry Could Hit $7 Billion in Sales
Business Wire / Posted 8 days ago
TAMPA, Fla.--(BUSINESS WIRE)--As Neutra Corp. (OTCQB: NTRR) and other wellness companies prepare for the expected nationwide legalization of cannabis in Canada, an economist at a major investment bank estimates that the country’s cannabis market... Read more
10d
San Antonio Express-News
Why GW Pharmaceuticals Shares Tumbled 25% in JanuaryImage source: GW Pharmaceuticals, plc. What: Following reports that the compan
Why GW Pharmaceuticals Shares Tumbled 25% in January
San Antonio Express-News / Posted 10 days ago
Image source: GW Pharmaceuticals, plc. What: Following reports that the company's financials may lack adequate accounting controls, shares in GW Pharmaceuticals, plc fell 25.3% in January, according to S&P Capital IQ. So what: Early last month, the... Read more
3 related stories
16d
Daily Telegraph
Up 300pc in five years: 'This investment story is still intact'The sell-off we have seen since the start of the year really can’t be justified
Up 300pc in five years: 'This investment story is still intact'
Daily Telegraph / Posted 16 days ago
The sell-off we have seen since the start of the year really can’t be justified. It’s to do with the slowdown in China and the falling oil price. Biotech has no exposure to any of that. Our chart (see below) shows that previously when the big... Read more
16d
FOX News
Cannabis drug shows promise in treating schizophreniaAn experimental cannabis drug for treating schizophrenia, developed by UK-based
Cannabis drug shows promise in treating schizophrenia
FOX News / Posted 16 days ago
An experimental cannabis drug for treating schizophrenia, developed by UK-based GW Pharmaceuticals Plc, was found to be superior to a placebo in a mid-stage trial. The company's UK-listed shares jumped 12.5 percent, while U.S.-listed shares were up... Read more
17d
Business Wire
Robbins Arroyo LLP: GW Pharmaceuticals plc (GWPH) Misled Shareholders According to a Recently Filed Class ActionSAN DIEGO & CAMBRIDGE, England--(BUSINESS WIRE)--Shareholder rights law firm Ro
Robbins Arroyo LLP: GW Pharmaceuticals plc (GWPH) Misled Shareholders According to a Recently Filed Class Action
Business Wire / Posted 17 days ago
SAN DIEGO & CAMBRIDGE, England--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed in the U.S. District Court for the Southern District of New York. The complaint alleges that officers... Read more
20d
Australian Broadcasting Corporation
Cannabis-based drug to be made available to NSW children with epilepsy A small number of children with drug-resistant epilepsy will so
Cannabis-based drug to be made available to NSW children
Australian Broadcasting Corporation / Posted 20 days ago
with epilepsy A small number of children with drug-resistant epilepsy will soon be able to access a new cannabis-based drug in New South Wales which is showing promise in relieving the... Read more
21d
Daily Telegraph
Kids' cannabis trials leading the worldChildren allowed to use medicinal cannabis ahead of world-first drug trials in
Kids' cannabis trials leading the world
Daily Telegraph / Posted 21 days ago
Children allowed to use medicinal cannabis ahead of world-first drug trials in NSW | DailyTelegraph SearchUse keywords to search content on this website SearchUse keywords to search content on this website Sonya and Tim Reynolds with daughters... Read more
23d
Reuters
Marijuana Inc. eyes Mexico as drug liberalization loomsMEXICO CITY Many top companies cashing in on legal cannabis are considering a b
Marijuana Inc. eyes Mexico as drug liberalization looms
Reuters / Posted 23 days ago
MEXICO CITY Many top companies cashing in on legal cannabis are considering a bet on Mexico after a Supreme Court decision raised hopes for a legalization of medical and recreational marijuana in a country reeling from years of gruesome drug... Read more
24d
Business Wire
NTRR Joint Venture Partner Prepares to Launch BeKind Topicals Brand in Explosive Cannabis MarketTAMPA, Fla.--(BUSINESS WIRE)--Neutra Corp. (OTCQB:NTRR) joint venture partner O
NTRR Joint Venture Partner Prepares to Launch BeKind Topicals Brand in Explosive Cannabis Market
Business Wire / Posted 24 days ago
TAMPA, Fla.--(BUSINESS WIRE)--Neutra Corp. (OTCQB:NTRR) joint venture partner Oceanview Health Services Ltd. is making the necessary preparations to debut a new brand of cannabis-infused topical products, BeKind Topicals, in markets where cannabis is... Read more
24d
TheStreet.com
8 things that could lift biotech stocks out of Bear MarketThere is no single remedy to the biotech bear market of 2016. Biotech stocks a
8 things that could lift biotech stocks out of Bear Market
TheStreet.com / Posted 24 days ago
There is no single remedy to the biotech bear market of 2016. Biotech stocks are buried in a deep hole. To climb out, companies will have to generate some positive news. The sentiment in the sector right now is grim, so someone better start... Read more
29d
East Bay Express
Medical Miracle: More Proof Cannabis Treats Some Incurable EpilepsyResearchers at UC San Francisco added more proof to claims that medical cannabi
Medical Miracle: More Proof Cannabis Treats Some Incurable Epilepsy
East Bay Express / Posted 29 days ago
Researchers at UC San Francisco added more proof to claims that medical cannabis can treat incurable childhood epilepsy. UCSF announced last week that a pot extract reduced incurable seizures by an average of 36.5 percent in a group of 162 children... Read more

People in this news